Risk of Latent Tuberculosis Reactivation after Hematopoietic cell Transplantation

Matthew P. Cheng; Amanda E. Kusztos; Tyler D. Bold; Vincent T. Ho; Brett E. Glotzbecker; Candace Hsieh; Meghan A. Baker; Lindsey R. Baden; Sarah P. Hammond; Francisco M. Marty

doi:10.1093/cid/ciz048

Risk of Latent Tuberculosis Reactivation after Hematopoietic cell Transplantation

Matthew P. Cheng, Amanda E. Kusztos, Tyler D. Bold, Vincent T. Ho, Brett E. Glotzbecker, Candace Hsieh, Meghan A. Baker, Lindsey R. Baden, Sarah P. Hammond, Francisco M. Marty

Medicine - Infectious Disease and International

Research output: Contribution to journal › Article › peer-review

20 Scopus citations

Abstract

There were no cases of tuberculosis in a cohort of 2531 patients who underwent hematopoietic cell transplantation from 2010 to 2015 after 7323 person-years of follow up (95% confidence interval [CI], 0.0-0.05 cases/100 person-years), including 29 (1.15%) patients with untreated latent tuberculosis after 89 person-years of follow-up (95% CI, 0.0-4.06 cases/100 person-years).

Original language	English (US)
Article number	ciz048
Pages (from-to)	869-872
Number of pages	4
Journal	Clinical Infectious Diseases
Volume	69
Issue number	5
DOIs	https://doi.org/10.1093/cid/ciz048
State	Published - Aug 16 2019

Bibliographical note

Funding Information:
Financial support. M. P. C. receives salary support from a postdoctoral training grant, provided by the Fonds de recherche Santé Québec.

Funding Information:
Potential conflicts of interest. This article was prepared as part of routine work. S. P. H. reports research funding from Merck. All other authors report no potential conflicts. The authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Funding Information:
M. P. C. receives salary support from a postdoctoral training grant, provided by the Fonds de recherche Sant? Qu?bec.

Publisher Copyright:
© 2019 The Author(s) 2019.

Keywords

LTBI
Mycobacterium tuberculosis
TB
allogeneic
hematopoietic cell transplantation

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access

10.1093/cid/ciz048

OpenUrl availability

Full text

Cite this

@article{4dfa503b6ef84394bf63cfb7cfed3069,

title = "Risk of Latent Tuberculosis Reactivation after Hematopoietic cell Transplantation",

abstract = "There were no cases of tuberculosis in a cohort of 2531 patients who underwent hematopoietic cell transplantation from 2010 to 2015 after 7323 person-years of follow up (95% confidence interval [CI], 0.0-0.05 cases/100 person-years), including 29 (1.15%) patients with untreated latent tuberculosis after 89 person-years of follow-up (95% CI, 0.0-4.06 cases/100 person-years).",

keywords = "LTBI, Mycobacterium tuberculosis, TB, allogeneic, hematopoietic cell transplantation",

author = "Cheng, {Matthew P.} and Kusztos, {Amanda E.} and Bold, {Tyler D.} and Ho, {Vincent T.} and Glotzbecker, {Brett E.} and Candace Hsieh and Baker, {Meghan A.} and Baden, {Lindsey R.} and Hammond, {Sarah P.} and Marty, {Francisco M.}",

note = "Funding Information: Financial support. M. P. C. receives salary support from a postdoctoral training grant, provided by the Fonds de recherche Sant{\'e} Qu{\'e}bec. Funding Information: Potential conflicts of interest. This article was prepared as part of routine work. S. P. H. reports research funding from Merck. All other authors report no potential conflicts. The authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. Funding Information: M. P. C. receives salary support from a postdoctoral training grant, provided by the Fonds de recherche Sant? Qu?bec. Publisher Copyright: {\textcopyright} 2019 The Author(s) 2019.",

year = "2019",

month = aug,

day = "16",

doi = "10.1093/cid/ciz048",

language = "English (US)",

volume = "69",

pages = "869--872",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "5",

}

TY - JOUR

T1 - Risk of Latent Tuberculosis Reactivation after Hematopoietic cell Transplantation

AU - Cheng, Matthew P.

AU - Kusztos, Amanda E.

AU - Bold, Tyler D.

AU - Ho, Vincent T.

AU - Glotzbecker, Brett E.

AU - Hsieh, Candace

AU - Baker, Meghan A.

AU - Baden, Lindsey R.

AU - Hammond, Sarah P.

AU - Marty, Francisco M.

N1 - Funding Information: Financial support. M. P. C. receives salary support from a postdoctoral training grant, provided by the Fonds de recherche Santé Québec. Funding Information: Potential conflicts of interest. This article was prepared as part of routine work. S. P. H. reports research funding from Merck. All other authors report no potential conflicts. The authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. Funding Information: M. P. C. receives salary support from a postdoctoral training grant, provided by the Fonds de recherche Sant? Qu?bec. Publisher Copyright: © 2019 The Author(s) 2019.

PY - 2019/8/16

Y1 - 2019/8/16

N2 - There were no cases of tuberculosis in a cohort of 2531 patients who underwent hematopoietic cell transplantation from 2010 to 2015 after 7323 person-years of follow up (95% confidence interval [CI], 0.0-0.05 cases/100 person-years), including 29 (1.15%) patients with untreated latent tuberculosis after 89 person-years of follow-up (95% CI, 0.0-4.06 cases/100 person-years).

AB - There were no cases of tuberculosis in a cohort of 2531 patients who underwent hematopoietic cell transplantation from 2010 to 2015 after 7323 person-years of follow up (95% confidence interval [CI], 0.0-0.05 cases/100 person-years), including 29 (1.15%) patients with untreated latent tuberculosis after 89 person-years of follow-up (95% CI, 0.0-4.06 cases/100 person-years).

KW - LTBI

KW - Mycobacterium tuberculosis

KW - TB

KW - allogeneic

KW - hematopoietic cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=85071182752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071182752&partnerID=8YFLogxK

U2 - 10.1093/cid/ciz048

DO - 10.1093/cid/ciz048

M3 - Article

C2 - 30689792

AN - SCOPUS:85071182752

SN - 1058-4838

VL - 69

SP - 869

EP - 872

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 5

M1 - ciz048

ER -

Risk of Latent Tuberculosis Reactivation after Hematopoietic cell Transplantation

Abstract

Bibliographical note

Keywords

UN SDGs

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this